Table 2. Assessment of the necrosis and degeneration.
Alternations/Groups | Con. | Puer. (50mg/kg) | Cispt | Cispt+10mg/kg Puer | Cispt+30mg/kg Puer | Cispt+50mg/kg Puer. |
---|---|---|---|---|---|---|
Necrosis and degeneration | 0.00±0.00 | 0.00±0.00 | 3.48±0.26a | 3.15±0.18b | 2.31±0.15c | 1.22±0.19c |
a P<0.05 vs. Control group
b P>0.05 vs. Cisplatin group
c P<0.05 vs. Cisplatin group. Values are presented as the mean ± SD.
Note: Con.: control; Cispt: cisplatin; Puer.: Puerarin.